Login / Signup

The Discovery and Biosynthesis of Nicotinic Myxochelins from an Archangium sp. SDU34.

De-Gao WangLuo NiuZhao-Min LinJing-Jing WangDong-Fang GaoHai-Yan SuiYue-Zhong LiChangsheng Wu
Published in: Journal of natural products (2021)
Myxobacteria are a prolific source of structurally diverse natural products, and one of the best-studied myxobacterial products is the siderophore myxochelin. Herein, we report two new compounds, myxochelins N (1) and O (2), that are nicotinic paralogs of myxochelin A, from the terrestrial myxobacterium Archangium sp. SDU34; 2 is functionalized with a rare 2-oxazolidinone. A precursor-feeding experiment implied that the biosynthesis of 1 or 2 was due to altered substrate specificity of the loading module of MxcE, which likely accepts nicotinic acid and benzoic acid instead of more conventional 2,3-dihydroxybenzoic acid. We also employed a phylogenomic approach to map the evolutionary relationships of the myxochelin biosynthetic gene clusters (BGCs) in all the available myxobacterial genomes, to pave the way for the future discovery of potentially hidden myxochelin derivatives. Although the biological function of 1 and 2 is unclear yet, this work underpins that even extensively studied BGCs in myxobacteria can still produce new chemistry.
Keyphrases
  • small molecule
  • high throughput
  • multidrug resistant
  • copy number
  • current status
  • cell wall
  • single cell
  • drug discovery
  • liquid chromatography
  • genome wide identification